生物活性
Brevianamide F(Cyclo(L-Pro-L-Trp))是从Colletotrichum gloeosporioides中分离得到的一种真菌毒素,具有抗菌活性。此外,Brevianamide F还表现出PI3Kα抑制活性,其IC50值为4.8 μM。
靶点
体外研究
Brevianamide F对金黄色葡萄球菌(MSSA)和耐甲氧西林金黄色葡萄球菌(MRSA)均表现出中等活性。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
色氨酰-脯氨酸 | Trp-Pro | 38136-75-3 | C16H19N3O3 | 301.345 |
—— | Boc-Trp-Pro-OMe | 85416-63-3 | C22H29N3O5 | 415.489 |
—— | N-carbobenzyloxy-L-tryptophanyl-L-proline methyl ester | 55782-87-1 | C25H27N3O5 | 449.506 |
—— | methyl 4-[3-[[(3S,8aS)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-1H-indol-2-yl]benzoate | —— | C22H26N3O3Pol | 417.5 |
—— | Boc-Pro-Trp-OMe | 608146-30-1 | C22H29N3O5 | 415.489 |
—— | D-alanyl-L-tryptophan methyl ester | 204980-52-9 | C15H19N3O3 | 289.334 |
N-叔丁氧羰基-L-色氨酸 | Boc-Trp-OH | 13139-14-5 | C16H20N2O4 | 304.346 |
N-苄氧羰基-L-色氨酸 | N-carbobenzyloxy-L-tryptophan | 7432-21-5 | C19H18N2O4 | 338.363 |
L-色氨酸 | L-Tryptophan | 73-22-3 | C11H12N2O2 | 204.228 |
L-色氨酸甲酯 | L-tryptophan methyl ester | 4299-70-1 | C12H14N2O2 | 218.255 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | cyclo-L-prolyl-6-methoxy-L-tryptophyl | 79950-61-1 | C17H19N3O3 | 313.356 |
—— | N-prenyl-cyclo-L-tryptophyl-L-proline | 73093-48-8 | C21H25N3O2 | 351.448 |
—— | tryprostatin B | 179936-52-8 | C21H25N3O2 | 351.448 |
(3S,8aS)-3-[[2-(2-甲基丁-3-烯-2-基)-1H-吲哚-3-基]甲基]-2,3,6,7,8,8a-六氢吡咯并[2,1-f]吡嗪-1,4-二酮 | deoxybrevianamide E | 34610-68-9 | C21H25N3O2 | 351.448 |
—— | (-)-aspergilazine A | —— | C32H32N6O4 | 564.644 |
—— | tert-butyl 3-(((3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl)methyl)-1H-indole-1-carboxylate | 310462-38-5 | C21H25N3O4 | 383.447 |
—— | (3S,8aS)-3-((2-(p-tolyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-26-3 | C23H23N3O2 | 373.455 |
—— | (3S,8aS)-3-[2'-(3'',3''-dimethyl-3''-trifluoroacetoxypropyl)-3'-indolylmethyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 336130-50-8 | C23H26F3N3O4 | 465.472 |
—— | (3S,8aS)-3-[2-(3-methylbutyryl)-1H-indol-3-ylmethyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 123251-58-1 | C21H25N3O3 | 367.448 |
—— | (3S,8aS)-3-((2-(4-chlorophenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-29-6 | C22H20ClN3O2 | 393.873 |
—— | (3S,8aS)-3-((2-(4-methoxyphenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-27-4 | C23H23N3O3 | 389.454 |
—— | (3S,8aS)-3-((2-(4-(trifluoromethyl)phenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-28-5 | C23H20F3N3O2 | 427.426 |
—— | methyl 4-[3-[[(3S,8aS)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-3-yl]methyl]-1H-indol-2-yl]benzoate | —— | C22H26N3O3Pol | 417.5 |
—— | (3S,8aS)-3-((2-(2-chlorophenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-33-2 | C22H20ClN3O2 | 393.873 |
—— | (3S,8aS)-3-((2-(3,5-bis(trifluoromethyl)phenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-38-7 | C24H19F6N3O2 | 495.424 |
—— | (3S,8aS)-3-((2-(2-(trifluoromethyl)phenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-32-1 | C23H20F3N3O2 | 427.426 |
—— | (3S,8aS)-3-((2-(2-methoxyphenyl)-1H-indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | 1454306-31-0 | C23H23N3O3 | 389.454 |
—— | naseseazine A | 1179325-41-7 | C30H30N6O4 | 538.606 |
—— | (+)-naseseazine B | 1179325-42-8 | C32H32N6O4 | 564.644 |
—— | (+)-naseseazine B | —— | C32H32N6O4 | 564.644 |
Selective C–C and C–N oxidative couplings on tryptophan-based diketopiperazines allow the direct access to two novel scaffolds.